Medical Care
Global Invasive Fungal Disease (IFD) Drugs Market Research Report 2026
- May 01, 26
- ID: 754196
- Pages: 105
- Figures: 107
- Views: 2
This report delivers a comprehensive overview of the global Invasive Fungal Disease (IFD) Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Invasive Fungal Disease (IFD) Drugs. The Invasive Fungal Disease (IFD) Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Invasive Fungal Disease (IFD) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Invasive Fungal Disease (IFD) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Merck
Gilead Sciences
Xellia
Lupin Limited
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical
Segment by Type
Oral Medicine
Injectable Medicine
Segment by Application
Hospital
Drugstore
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Invasive Fungal Disease (IFD) Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Invasive Fungal Disease (IFD) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Invasive Fungal Disease (IFD) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Merck
Gilead Sciences
Xellia
Lupin Limited
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical
Segment by Type
Oral Medicine
Injectable Medicine
Segment by Application
Hospital
Drugstore
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Invasive Fungal Disease (IFD) Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Medicine
1.2.3 Injectable Medicine
1.3 Market by Application
1.3.1 Global Invasive Fungal Disease (IFD) Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Invasive Fungal Disease (IFD) Drugs Market Perspective (2021–2032)
2.2 Global Invasive Fungal Disease (IFD) Drugs Growth Trends by Region
2.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Invasive Fungal Disease (IFD) Drugs Historic Market Size by Region (2021–2026)
2.2.3 Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (2027–2032)
2.3 Invasive Fungal Disease (IFD) Drugs Market Dynamics
2.3.1 Invasive Fungal Disease (IFD) Drugs Industry Trends
2.3.2 Invasive Fungal Disease (IFD) Drugs Market Drivers
2.3.3 Invasive Fungal Disease (IFD) Drugs Market Challenges
2.3.4 Invasive Fungal Disease (IFD) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue
3.1.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue (2021–2026)
3.1.2 Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Invasive Fungal Disease (IFD) Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Invasive Fungal Disease (IFD) Drugs Revenue
3.4 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio
3.4.1 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Disease (IFD) Drugs Revenue in 2025
3.5 Global Key Players of Invasive Fungal Disease (IFD) Drugs Head Offices and Areas Served
3.6 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications
3.7 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Type
4.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Type (2021–2026)
4.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (2027–2032)
5 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Application
5.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Application (2021–2026)
5.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
6.2 North America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
6.4 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
7.2 Europe Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
7.4 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
8.2 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
9.2 Latin America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
9.4 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
10.2 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Invasive Fungal Disease (IFD) Drugs Introduction
11.1.4 Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Invasive Fungal Disease (IFD) Drugs Introduction
11.2.4 Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.2.5 Merck Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Introduction
11.3.4 Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Xellia
11.4.1 Xellia Company Details
11.4.2 Xellia Business Overview
11.4.3 Xellia Invasive Fungal Disease (IFD) Drugs Introduction
11.4.4 Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.4.5 Xellia Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Invasive Fungal Disease (IFD) Drugs Introduction
11.5.4 Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.5.5 Lupin Limited Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Disease (IFD) Drugs Introduction
11.6.4 Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.6.5 Abbott Recent Development
11.7 Creogenic Pharma
11.7.1 Creogenic Pharma Company Details
11.7.2 Creogenic Pharma Business Overview
11.7.3 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.7.4 Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.7.5 Creogenic Pharma Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Company Details
11.8.2 Taj Pharmaceuticals Business Overview
11.8.3 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Introduction
11.8.4 Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.9.4 Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.9.5 Astellas Pharma Recent Development
11.10 Jiangsu Aosaikang Pharmaceutical
11.10.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.10.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.10.3 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Introduction
11.10.4 Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.10.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Medicine
1.2.3 Injectable Medicine
1.3 Market by Application
1.3.1 Global Invasive Fungal Disease (IFD) Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Invasive Fungal Disease (IFD) Drugs Market Perspective (2021–2032)
2.2 Global Invasive Fungal Disease (IFD) Drugs Growth Trends by Region
2.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Invasive Fungal Disease (IFD) Drugs Historic Market Size by Region (2021–2026)
2.2.3 Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (2027–2032)
2.3 Invasive Fungal Disease (IFD) Drugs Market Dynamics
2.3.1 Invasive Fungal Disease (IFD) Drugs Industry Trends
2.3.2 Invasive Fungal Disease (IFD) Drugs Market Drivers
2.3.3 Invasive Fungal Disease (IFD) Drugs Market Challenges
2.3.4 Invasive Fungal Disease (IFD) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue
3.1.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue (2021–2026)
3.1.2 Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Invasive Fungal Disease (IFD) Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Invasive Fungal Disease (IFD) Drugs Revenue
3.4 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio
3.4.1 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Disease (IFD) Drugs Revenue in 2025
3.5 Global Key Players of Invasive Fungal Disease (IFD) Drugs Head Offices and Areas Served
3.6 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications
3.7 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Type
4.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Type (2021–2026)
4.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (2027–2032)
5 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Application
5.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Application (2021–2026)
5.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
6.2 North America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
6.4 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
7.2 Europe Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
7.4 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
8.2 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
9.2 Latin America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
9.4 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)
10.2 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Invasive Fungal Disease (IFD) Drugs Introduction
11.1.4 Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Invasive Fungal Disease (IFD) Drugs Introduction
11.2.4 Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.2.5 Merck Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Introduction
11.3.4 Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Xellia
11.4.1 Xellia Company Details
11.4.2 Xellia Business Overview
11.4.3 Xellia Invasive Fungal Disease (IFD) Drugs Introduction
11.4.4 Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.4.5 Xellia Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Invasive Fungal Disease (IFD) Drugs Introduction
11.5.4 Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.5.5 Lupin Limited Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Disease (IFD) Drugs Introduction
11.6.4 Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.6.5 Abbott Recent Development
11.7 Creogenic Pharma
11.7.1 Creogenic Pharma Company Details
11.7.2 Creogenic Pharma Business Overview
11.7.3 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.7.4 Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.7.5 Creogenic Pharma Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Company Details
11.8.2 Taj Pharmaceuticals Business Overview
11.8.3 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Introduction
11.8.4 Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.9.4 Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.9.5 Astellas Pharma Recent Development
11.10 Jiangsu Aosaikang Pharmaceutical
11.10.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.10.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.10.3 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Introduction
11.10.4 Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
11.10.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injectable Medicine
Table 4. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026
Table 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2026)
Table 8. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2027–2032)
Table 10. Invasive Fungal Disease (IFD) Drugs Market Trends
Table 11. Invasive Fungal Disease (IFD) Drugs Market Drivers
Table 12. Invasive Fungal Disease (IFD) Drugs Market Challenges
Table 13. Invasive Fungal Disease (IFD) Drugs Market Restraints
Table 14. Global Invasive Fungal Disease (IFD) Drugs Revenue by Players (US$ Million), 2021–2026
Table 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players (2021–2026)
Table 16. Global Top Invasive Fungal Disease (IFD) Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Invasive Fungal Disease (IFD) Drugs Revenue, 2025
Table 17. Ranking of Global Top Invasive Fungal Disease (IFD) Drugs Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Headquarters and Area Served
Table 20. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications
Table 21. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Invasive Fungal Disease (IFD) Drugs Market Size by Type (US$ Million), 2021–2026
Table 24. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2021–2026)
Table 25. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2027–2032)
Table 27. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2026
Table 28. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2021–2026)
Table 29. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2027–2032)
Table 31. North America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 33. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Invasive Fungal Disease (IFD) Drugs Product
Table 49. Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 50. Pfizer Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Invasive Fungal Disease (IFD) Drugs Product
Table 54. Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 55. Merck Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Invasive Fungal Disease (IFD) Drugs Product
Table 59. Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 60. Gilead Sciences Recent Development
Table 61. Xellia Company Details
Table 62. Xellia Business Overview
Table 63. Xellia Invasive Fungal Disease (IFD) Drugs Product
Table 64. Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 65. Xellia Recent Development
Table 66. Lupin Limited Company Details
Table 67. Lupin Limited Business Overview
Table 68. Lupin Limited Invasive Fungal Disease (IFD) Drugs Product
Table 69. Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 70. Lupin Limited Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Invasive Fungal Disease (IFD) Drugs Product
Table 74. Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 75. Abbott Recent Development
Table 76. Creogenic Pharma Company Details
Table 77. Creogenic Pharma Business Overview
Table 78. Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 79. Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 80. Creogenic Pharma Recent Development
Table 81. Taj Pharmaceuticals Company Details
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Product
Table 84. Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 89. Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 90. Astellas Pharma Recent Development
Table 91. Jiangsu Aosaikang Pharmaceutical Company Details
Table 92. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 93. Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Product
Table 94. Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 95. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Invasive Fungal Disease (IFD) Drugs Picture
Figure 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Invasive Fungal Disease (IFD) Drugs Market Share by Type: 2025 vs 2032
Figure 4. Oral Medicine Features
Figure 5. Injectable Medicine Features
Figure 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Drugstore Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Invasive Fungal Disease (IFD) Drugs Report Years Considered
Figure 13. Global Invasive Fungal Disease (IFD) Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Invasive Fungal Disease (IFD) Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region: 2025 vs 2032
Figure 16. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players in 2025
Figure 17. Global Invasive Fungal Disease (IFD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue in 2025
Figure 19. North America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 21. United States Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 25. Germany Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2032)
Figure 33. China Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 41. Mexico Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 45. Israel Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Pfizer Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 49. Merck Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 50. Gilead Sciences Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 51. Xellia Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 52. Lupin Limited Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 53. Abbott Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 54. Creogenic Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 55. Taj Pharmaceuticals Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 56. Astellas Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 57. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injectable Medicine
Table 4. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026
Table 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2026)
Table 8. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2027–2032)
Table 10. Invasive Fungal Disease (IFD) Drugs Market Trends
Table 11. Invasive Fungal Disease (IFD) Drugs Market Drivers
Table 12. Invasive Fungal Disease (IFD) Drugs Market Challenges
Table 13. Invasive Fungal Disease (IFD) Drugs Market Restraints
Table 14. Global Invasive Fungal Disease (IFD) Drugs Revenue by Players (US$ Million), 2021–2026
Table 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players (2021–2026)
Table 16. Global Top Invasive Fungal Disease (IFD) Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Invasive Fungal Disease (IFD) Drugs Revenue, 2025
Table 17. Ranking of Global Top Invasive Fungal Disease (IFD) Drugs Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Headquarters and Area Served
Table 20. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications
Table 21. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Invasive Fungal Disease (IFD) Drugs Market Size by Type (US$ Million), 2021–2026
Table 24. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2021–2026)
Table 25. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2027–2032)
Table 27. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2026
Table 28. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2021–2026)
Table 29. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2027–2032)
Table 31. North America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 33. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Invasive Fungal Disease (IFD) Drugs Product
Table 49. Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 50. Pfizer Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Invasive Fungal Disease (IFD) Drugs Product
Table 54. Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 55. Merck Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Invasive Fungal Disease (IFD) Drugs Product
Table 59. Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 60. Gilead Sciences Recent Development
Table 61. Xellia Company Details
Table 62. Xellia Business Overview
Table 63. Xellia Invasive Fungal Disease (IFD) Drugs Product
Table 64. Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 65. Xellia Recent Development
Table 66. Lupin Limited Company Details
Table 67. Lupin Limited Business Overview
Table 68. Lupin Limited Invasive Fungal Disease (IFD) Drugs Product
Table 69. Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 70. Lupin Limited Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Invasive Fungal Disease (IFD) Drugs Product
Table 74. Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 75. Abbott Recent Development
Table 76. Creogenic Pharma Company Details
Table 77. Creogenic Pharma Business Overview
Table 78. Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 79. Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 80. Creogenic Pharma Recent Development
Table 81. Taj Pharmaceuticals Company Details
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Product
Table 84. Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 89. Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 90. Astellas Pharma Recent Development
Table 91. Jiangsu Aosaikang Pharmaceutical Company Details
Table 92. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 93. Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Product
Table 94. Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026
Table 95. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Invasive Fungal Disease (IFD) Drugs Picture
Figure 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Invasive Fungal Disease (IFD) Drugs Market Share by Type: 2025 vs 2032
Figure 4. Oral Medicine Features
Figure 5. Injectable Medicine Features
Figure 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Drugstore Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Invasive Fungal Disease (IFD) Drugs Report Years Considered
Figure 13. Global Invasive Fungal Disease (IFD) Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Invasive Fungal Disease (IFD) Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region: 2025 vs 2032
Figure 16. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players in 2025
Figure 17. Global Invasive Fungal Disease (IFD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue in 2025
Figure 19. North America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 21. United States Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 25. Germany Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2032)
Figure 33. China Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 41. Mexico Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)
Figure 45. Israel Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Pfizer Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 49. Merck Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 50. Gilead Sciences Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 51. Xellia Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 52. Lupin Limited Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 53. Abbott Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 54. Creogenic Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 55. Taj Pharmaceuticals Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 56. Astellas Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 57. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232